A DETAILED STUDY OF THE EFFECTS OF INVITRO INTERFERON TREATMENT ON THE GROWTH OF 2 VARIANTS OF THE B16 MOUSE MELANOMA IN THE LUNGS - EVIDENCE FOR NONSPECIFIC EFFECTS

被引:1
作者
BLACKMORE, M [1 ]
THOMPSON, S [1 ]
TURNER, GA [1 ]
机构
[1] UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE2 4HH,ENGLAND
关键词
D O I
10.1007/BF00058155
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interferon treatment increases the ability of tumour cells to colonize the lungs. Although it has been suggested that this effect can be explained by increases in the expression of MHC molecules the precise mechanism is still uncertain. The growth in the lungs of a low (F1) and a high colonizing variant (BL6) of the B16 mouse melanoma have been studied after in vitro treatment with interferon. Interferon-gamma, but not interferon-alpha/beta, increased the number of lung colonies formed after intraveneous injection, but not after subcutaneous administration. Treatment also increased the sizes of the lung colonies formed and the number of radiolabelled cells retained by the lungs. However, no clear relationship was observed between the number of colonies formed and the concentration of interferon used. The effect of interferon on F1 was greater than on BL6, but the overall number of colonies formed was very similar. These results suggest that interferon increases the adhesiveness of these cell lines in a fairly non-specific manner, that seems unlikely to involve MHC molecules. As a result of this and other studies the importance of interferon in the process of tumour spread seems very questionable. © 1990 Taylor & Francis Ltd.
引用
收藏
页码:449 / 460
页数:12
相关论文
共 22 条
[1]  
CHERVENAK R, 1988, J IMMUNOL, V140, P3712
[2]   MHC IMBALANCE AND METASTATIC SPREAD IN LEWIS LUNG-CARCINOMA CLONES [J].
EISENBACH, L ;
SEGAL, S ;
FELDMAN, M .
INTERNATIONAL JOURNAL OF CANCER, 1983, 32 (01) :113-120
[3]   STUDIES ON THE EXPRESSION OF H-2-ANTIGENS IN NON-METASTATIC AND HIGHLY METASTATIC FRIEND-ERYTHROLEUKEMIA CELLS - CORRELATION WITH THE INVIVO BEHAVIOR OF TUMOR-CELLS [J].
FERRANTINI, M ;
PULCIANI, S ;
PROIETTI, E ;
LESPINATS, G ;
ANASTASI, A ;
CIOLLI, V ;
RIZZA, P ;
BELARDELLI, F .
CLINICAL & EXPERIMENTAL METASTASIS, 1989, 7 (06) :609-625
[4]  
FIDLER IJ, 1975, CANCER RES, V35, P218
[5]   EFFECTS OF INTERFERON ON DIFFERENTIATION OF NORMAL AND TUMOR-CELLS [J].
FISHER, PB ;
GRANT, S .
PHARMACOLOGY & THERAPEUTICS, 1985, 27 (02) :143-166
[6]  
GIACOMINI P, 1988, J IMMUNOL, V140, P3073
[7]  
GORELIK E, 1988, J IMMUNOL, V140, P2096
[8]   ANTI-TUMOR EFFECTS OF INTERFERON [J].
GRESSER, I ;
TOVEY, MG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1978, 516 (02) :231-247
[9]  
HART IR, 1979, AM J PATHOL, V97, P587
[10]   IMMUNO-SELECTION INVIVO OF H-2D PHENOTYPIC VARIANTS FROM A METASTATIC CLONE OF SARCOMA-CELLS RESULTS IN CELL-LINES OF ALTERED METASTATIC COMPETENCE [J].
KATZAV, S ;
SEGAL, S ;
FELDMAN, M .
INTERNATIONAL JOURNAL OF CANCER, 1984, 33 (03) :407-415